| 1157 |
Activation, Hepatic nuclear receptor(s)
Short Name
Activation, Hepatic nuclear receptor(s)
|
1 |
Molecular |
Nov 29, 2016 |
Nov 19, 2025 |
194: Hepatic nuclear receptor activation leading to altered amphibian metamorphosis
|
| 1156 |
Inhibition, Dual oxidase
Short Name
Inhibition, Dual oxidase
|
1 |
Molecular |
Nov 29, 2016 |
Nov 19, 2025 |
193: Dual oxidase (DUOX) inhibition leading to altered amphibian metamorphosis
|
| 1155 |
Inhibition, Pendrin
Short Name
Inhibition, Pendrin
|
1 |
Molecular |
Nov 29, 2016 |
Nov 19, 2025 |
192: Pendrin inhibition leading to altered amphibian metamorphosis
|
| 1154 |
Increased, Triiodothyronine (T3) in tissues
Short Name
Increased, Triiodothyronine (T3) in tissues
|
1 |
Tissue |
Nov 29, 2016 |
Dec 3, 2016 |
191: Type III iodotyrosine deiodinase (DIO3) inhibition leading to altered amphibian metamorphosis
|
| 1153 |
Inhibition, Deiodinase 3
Short Name
Inhibition, Deiodinase 3
|
1 |
Molecular |
Nov 29, 2016 |
Nov 19, 2025 |
191: Type III iodotyrosine deiodinase (DIO3) inhibition leading to altered amphibian metamorphosis
|
| 1152 |
Inhibition, Iodotyrosine deiodinase (IYD)
Short Name
Inhibition, Iodotyrosine deiodinase (IYD)
|
1 |
Molecular |
Nov 29, 2016 |
Nov 18, 2025 |
188: Iodotyrosine deiodinase (IYD) inhibition leading to altered amphibian metamorphosis
|
| 1151 |
Osteoporosis and vascular calcification, Bone deterioration
Short Name
Osteoporosis and vascular calcification, Bone deterioration
|
2 |
Individual |
Nov 29, 2016 |
Dec 3, 2016 |
187: Anticoagulant rodenticide inhibition of vitamin K epoxide reductase resulting coagulopathy and hemorrhage
|
| 1150 |
Uncarboxylated osteocalcin not incorporated into bone matrix, decreasing bone strength, Impaired function of osteocalcin and MGP
Short Name
Uncarboxylated osteocalcin not incorporated into bone matrix, decreasing bone strength, Imp
|
0 |
|
Nov 29, 2016 |
Nov 29, 2016 |
None
|
| 1149 |
Calcium cannot bind to the hydroxyapatite matrix of bone, Osteocalcin and other bone proteins (periostin, MGP and periostin like factor) not formed
Short Name
Calcium cannot bind to the hydroxyapatite matrix of bone, Osteocalcin and other bone protei
|
0 |
|
Nov 29, 2016 |
Nov 29, 2016 |
None
|
| 1148 |
Anticoagulant rodenticide interferes with gamma-carboxyglutamate formation, Inhibition of protein synthesis in bone
Short Name
Anticoagulant rodenticide interferes with gamma-carboxyglutamate formation, Inhibition of p
|
0 |
|
Nov 29, 2016 |
Nov 29, 2016 |
None
|
| 1147 |
increased or inappropriate, mantel display
Short Name
increased or inappropriate, mantel display
|
0 |
Individual |
Nov 29, 2016 |
Dec 3, 2016 |
None
|
| 1146 |
premature, Spawning
Short Name
premature, Spawning
|
0 |
Individual |
Nov 29, 2016 |
Jan 17, 2017 |
None
|
| 1145 |
Decreased, gametogenesis
Short Name
Decreased, gametogenesis
|
0 |
|
Nov 29, 2016 |
Nov 29, 2016 |
None
|
| 1144 |
premature, spawning 1 1
Short Name
premature, spawning 1
|
0 |
|
Nov 29, 2016 |
Nov 29, 2016 |
None
|
| 1143 |
Depletion, energy reserves
Short Name
Depletion, energy reserves
|
0 |
Individual |
Nov 29, 2016 |
Dec 3, 2016 |
97: 5-hydroxytryptamine transporter (5-HTT; SERT) inhibition leading to population decline
|
| 1142 |
Increased, valve movement
Short Name
Increased, valve movement
|
1 |
Tissue |
Nov 29, 2016 |
Dec 3, 2016 |
4 AOPs
|
| 1141 |
Decreased, Reproductive Success
Short Name
Decreased, Reproductive Success
|
0 |
Individual |
Nov 29, 2016 |
Dec 3, 2016 |
4 AOPs
|
| 1140 |
Delayed, Sexual maturity
Short Name
Delayed, Sexual maturity
|
0 |
Individual |
Nov 29, 2016 |
Dec 3, 2016 |
None
|
| 1139 |
Increased, water retention in foot
Short Name
Increased, water retention in foot
|
0 |
Organ |
Nov 29, 2016 |
Dec 3, 2016 |
97: 5-hydroxytryptamine transporter (5-HTT; SERT) inhibition leading to population decline
|
| 1138 |
Uncoupling of oxidative phosphorylation, Reduced ability to generate ATP
Short Name
Uncoupling of oxidative phosphorylation, Reduced ability to generate ATP
|
2 |
Molecular |
Nov 29, 2016 |
Sep 16, 2017 |
187: Anticoagulant rodenticide inhibition of vitamin K epoxide reductase resulting coagulopathy and hemorrhage
|
| 1137 |
Under carboxylation of osteocalcin, Failure to cycle vitamin K epoxide to vitamin K to form vitamin K hydroquinone
Short Name
Under carboxylation of osteocalcin, Failure to cycle vitamin K epoxide to vitamin K to form
|
0 |
|
Nov 29, 2016 |
Nov 29, 2016 |
None
|
| 1136 |
Impaired recruitment , Population trajectory
Short Name
Impaired recruitment , Population trajectory
|
1 |
Population |
Nov 29, 2016 |
Dec 3, 2016 |
187: Anticoagulant rodenticide inhibition of vitamin K epoxide reductase resulting coagulopathy and hemorrhage
|
| 1135 |
Reduced fitness or even mortality, Acidosis, hypovolemic shock and organ dysfunction
Short Name
Reduced fitness or even mortality, Acidosis, hypovolemic shock and organ dysfunction
|
5 |
Tissue |
Nov 29, 2016 |
Dec 3, 2016 |
187: Anticoagulant rodenticide inhibition of vitamin K epoxide reductase resulting coagulopathy and hemorrhage
|
| 1134 |
Irreversible inhibition of hepatic VKOR by binding of AR at tyrosine 139, Failure to cycle vitamin K epoxide to vitamin K to form vitamin K hydroquinone
Short Name
Irreversible inhibition of hepatic VKOR by binding of AR at tyrosine 139, Failure to cycle
|
3 |
Molecular |
Nov 29, 2016 |
Dec 3, 2016 |
187: Anticoagulant rodenticide inhibition of vitamin K epoxide reductase resulting coagulopathy and hemorrhage
|
| 1133 |
Hemostasis, Depletion from blood of fully functional carboxylated clotting factors
Short Name
Hemostasis, Depletion from blood of fully functional carboxylated clotting factors
|
2 |
Tissue |
Nov 29, 2016 |
Dec 3, 2016 |
187: Anticoagulant rodenticide inhibition of vitamin K epoxide reductase resulting coagulopathy and hemorrhage
|